Headache

Featured Article

Erenumab for Episodic Migraine: A Closer Look at the Data

Erenumab for Episodic Migraine: A Closer Look at the Data

For individuals with migraine frequency of 4 to 14 episodes per month, prophylactic medications and analgesics are required.

Latest

Fremanezumab Linked to Fewer Monthly Migraine Days

Fremanezumab Linked to Fewer Monthly Migraine Days

For patients with episodic migraine, fremanezumab is associated with a reduction in the mean number of monthly migraine days.

Galcanezumab Effective in Phase 3 Episodic Cluster Headache Study

Galcanezumab Effective in Phase 3 Episodic Cluster Headache Study

The episodic cluster headache trial included a total of 106 patients with an average of 17.5 cluster headache attacks per week at baseline.

Antidepressant Medications and Headache: Is There a Link?

Antidepressant Medications and Headache: Is There a Link?

Compared to placebo, selective serotonin reuptake inhibitors (SSRIs) were associated with a significantly higher risk of headache (risk ratio [RR] 1.06, 95% CI: 1.00 to 1.13; P =.045).

Results From Phase 3 Trial of Migraine Tx Ubrogepant Released

Results From Phase 3 Trial of Migraine Tx Ubrogepant Released

Allergan announced results from the second Phase 3 trial for their novel acute migraine treatment, ubrogepant.

Atraumatic Needles Reduce Headache Incidence Following Lumbar Puncture

Atraumatic Needles Reduce Headache Incidence Following Lumbar Puncture

Investigators assessed the impact of atraumatic vs conventional needles on patient outcomes after lumbar puncture.

Patient Develops Thunderclap Headaches After Consuming 'Carolina Reaper'

Patient Develops Thunderclap Headaches After Consuming 'Carolina Reaper'

The authors note that this appears to be the first case of RCVS secondary to pepper or cayenne ingestion.

Noninvasive Brain Stimulation May Help Prevent Migraines

Noninvasive Brain Stimulation May Help Prevent Migraines

Single-pulse transcranial magnetic stimulation device is safe and easy to use.

Novel Nasal Spray for Migraine Attacks to Be FDA Reviewed

Novel Nasal Spray for Migraine Attacks to Be FDA Reviewed

DFN-02 was evaluated in a multicenter, double-blind, randomized, placebo-controlled study (N=107) which showed it was effective in treating pain and associated symptoms during a migraine attack and in reducing attack-related functional disability.

Sumatriptan Self-Injection System No Longer Available

Sumatriptan Self-Injection System No Longer Available

Sumavel DosePro for the treatment of migraine or cluster headache has been discontinued.

Ubrogepant Effective for Acute Migraine Relief

Ubrogepant Effective for Acute Migraine Relief

Allergan has reported positive results from the first of 2 Phase 3 trials for ubrogepant for the treatment of migraine.

Sign Up for Free e-newsletters



CME Focus